Truvestments Capital LLC Novartis Ag Transaction History

Truvestments Capital LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $38,292 - $43,316	-478 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $53,615 - $59,220	-629 Reduced 56.82%	478 $44,000
Q1 2021 May 18, 2021	SELL	$83.5 - $98.47 $8,433 - $9,945	-101 Reduced 8.36%	1,107 $95,000
Q4 2020 Feb 17, 2021	BUY	$78.07 - $94.43 $37,083 - $44,854	475 Added 64.8%	1,208 $113,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $39,016 - $43,225	-475 Reduced 39.32%	733 $64,000
Q2 2020 Aug 06, 2020	SELL	$80.93 - $91.1 $2,670 - $3,006	-33 Reduced 2.66%	1,208 $105,000
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $87,701 - $122,871	1,241 New	1,241 $102,000
Q4 2019 Jan 29, 2020	SELL	$84.35 - $95.37 $43,271 - $48,924	-513 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$85.54 - $94.26 $2,309 - $2,545	-27 Reduced 5.0%	513 $45,000
Q2 2019 Jul 15, 2019	BUY	$75.4 - $92.8 $20,961 - $25,798	278 Added 106.11%	540 $49,000
Q1 2019 Apr 12, 2019	SELL	$75.32 - $86.15 $2,636 - $3,015	-35 Reduced 11.78%	262 $25,000
Q3 2018 Oct 22, 2018	BUY	$66.94 - $77.43 $19,881 - $22,996	297 New	297 $26,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.